[HTML][HTML] Neuropathology of Alzheimer's disease

JA Trejo-Lopez, AT Yachnis, S Prokop - Neurotherapeutics, 2023 - Elsevier
The key pathological hallmarks—extracellular plaques and intracellular neurofibrillary
tangles (NFT)—described by Alois Alzheimer in his seminal 1907 article are still central to …

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain, 2019 - academic.oup.com
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …

In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline

HIL Jacobs, JA Becker, K Kwong… - Science translational …, 2021 - science.org
Several autopsy studies recognize the locus coeruleus (LC) as the initial site of
hyperphosphorylated TAU aggregation, and as the number of LC neurons harboring TAU …

Molecular characterization of selectively vulnerable neurons in Alzheimer's disease

K Leng, E Li, R Eser, A Piergies, R Sit, M Tan… - Nature …, 2021 - nature.com
Alzheimer's disease (AD) is characterized by the selective vulnerability of specific neuronal
populations, the molecular signatures of which are largely unknown. To identify and …

The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline

HIL Jacobs, DA Hopkins, HC Mayrhofer, E Bruner… - Brain, 2018 - academic.oup.com
The cerebellum has long been regarded as essential only for the coordination of voluntary
motor activity and motor learning. Anatomical, clinical and neuroimaging studies have led to …

[HTML][HTML] The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease

BJ Matchett, LT Grinberg, P Theofilas, ME Murray - Acta neuropathologica, 2021 - Springer
Alzheimer's disease (AD) is neuropathologically characterized by the intracellular
accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β …

Long road to ruin: noradrenergic dysfunction in neurodegenerative disease

D Weinshenker - Trends in neurosciences, 2018 - cell.com
It has been known for decades that degeneration of the locus coeruleus (LC), the major
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …

[HTML][HTML] Cerebral iron deposition in neurodegeneration

P Dusek, T Hofer, J Alexander, PM Roos, JO Aaseth - Biomolecules, 2022 - mdpi.com
Disruption of cerebral iron regulation appears to have a role in aging and in the
pathogenesis of various neurodegenerative disorders. Possible unfavorable impacts of iron …

Late-onset Alzheimer disease

GD Rabinovici - Continuum: Lifelong Learning in Neurology, 2019 - journals.lww.com
PURPOSE OF REVIEW Alzheimer disease (AD) is the most common cause of late-onset
dementia. This article describes the epidemiology, genetic and environmental risk factors …

[HTML][HTML] Biomarkers for Alzheimer's disease early diagnosis

E Ausó, V Gómez-Vicente, G Esquiva - Journal of Personalized Medicine, 2020 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia, affecting the central
nervous system (CNS) through the accumulation of intraneuronal neurofibrillary tau tangles …